Although a non-redundant role of GSK-3α and GSK-3β in T cells has been established using conditional knockout mice, with the β isoform playing a dominant role over the GSK-3α, inhibition of both isoforms has been recently shown to be required to reduce PD-1 expression and enhance T cell-mediated tumor rejection [16]. Here, GSK3A is linked to neoplasm.